Literature DB >> 8551565

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

M G von Herrath1, M Yokoyama, J Dockter, M B Oldstone, J L Whitton.   

Abstract

Although primary antiviral CD8+ cytotoxic T lymphocytes (CTL) can be induced in mice depleted of CD4+ T cells, the role of CD4+ T lymphocytes in the generation and maintenance of antiviral memory CTL is uncertain. This question, and the consequences upon vaccine-mediated protection, were investigated in transgenic CD4 knockout (CD4ko) mice, which lack CD4+ T lymphocytes. Infection of immunocompetent C57BL/6 mice with lymphocytic choriomeningitis virus (LCMV), or with recombinant vaccinia viruses bearing appropriate LCMV sequences, induces long-lasting protective immunity, mediated mainly by antiviral CD8+ CTL. Here we report two important findings. First, LCMV-specific CD8+ memory CTL are maintained at considerably lower levels in CD4ko mice than in normal C57BL/6J mice; we demonstrate a reduction in precursor CTL evident as soon as 30 days postimmunization and declining, by day 120, to levels 1 to 2 log units below those in normal mice. Thus, CD4+ T cells appear to be important to the generation and maintenance of their CD8+ counterparts. Second, this reduction has an important biological consequence; compared with immunocompetent mice, CD4ko mice immunized with vaccinia virus recombinants expressing nucleoprotein or glycoprotein of LCMV are less effectively protected from subsequent LCMV challenge. Thus, this study underscores the potential importance of CD4+ T lymphocytes in generation of appropriate levels of CD(8+)-cell-mediated immunoprotective memory and has implications for vaccine efficacy in individuals with immune defects in which CD4 levels may be reduced, such as AIDS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551565      PMCID: PMC189913     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

1.  Apparent requirement for CD4+ T cells in primary anti-herpes simplex virus cytotoxic T-lymphocyte induction can be overcome by optimal antigen presentation.

Authors:  C M Mercadal; S Martin; B T Rouse
Journal:  Viral Immunol       Date:  1991       Impact factor: 2.257

2.  Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells.

Authors:  S Hou; P C Doherty; M Zijlstra; R Jaenisch; J M Katz
Journal:  J Immunol       Date:  1992-08-15       Impact factor: 5.422

3.  Activity of CD4+ T-cell clones of type 1 and type 2 in generation of influenza virus-specific cytotoxic responses in vitro.

Authors:  G Palladino; P A Scherle; W Gerhard
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

4.  Virus specificity of cytotoxic T lymphocytes generated during acute lymphocytic choriomeningitis virus infection: role of the H-2 region in determining cross-reactivity for different lymphocytic choriomeningitis virus strains.

Authors:  R Ahmed; J A Byrne; M B Oldstone
Journal:  J Virol       Date:  1984-07       Impact factor: 5.103

5.  Vaccinia and cowpox viruses encode a novel secreted interleukin-1-binding protein.

Authors:  M K Spriggs; D E Hruby; C R Maliszewski; D J Pickup; J E Sims; R M Buller; J VanSlyke
Journal:  Cell       Date:  1992-10-02       Impact factor: 41.582

6.  Antiviral immune responses of lymphocytic choriomeningitis virus-infected mice lacking CD8+ T lymphocytes because of disruption of the beta 2-microglobulin gene.

Authors:  F Lehmann-Grube; J Löhler; O Utermöhlen; C Gegin
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

7.  Mechanisms of antibody-mediated protection against lymphocytic choriomeningitis virus infection: mother-to-baby transfer of humoral protection.

Authors:  J R Baldridge; M J Buchmeier
Journal:  J Virol       Date:  1992-07       Impact factor: 5.103

8.  Normal development and function of CD8+ cells but markedly decreased helper cell activity in mice lacking CD4.

Authors:  A Rahemtulla; W P Fung-Leung; M W Schilham; T M Kündig; S R Sambhara; A Narendran; A Arabian; A Wakeham; C J Paige; R M Zinkernagel
Journal:  Nature       Date:  1991-09-12       Impact factor: 49.962

9.  Infection of lymphocytes by a virus that aborts cytotoxic T lymphocyte activity and establishes persistent infection.

Authors:  P Borrow; A Tishon; M B Oldstone
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

10.  Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells.

Authors:  M Eichelberger; W Allan; M Zijlstra; R Jaenisch; P C Doherty
Journal:  J Exp Med       Date:  1991-10-01       Impact factor: 14.307

View more
  85 in total

Review 1.  A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment.

Authors:  D Wodarz; K M Page; R A Arnaout; A R Thomsen; J D Lifson; M A Nowak
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2000-03-29       Impact factor: 6.237

Review 2.  T cell responses to viral infections: lessons from lymphocytic choriomeningitis virus.

Authors:  Aaruni Khanolkar; Michael J Fuller; Allan J Zajac
Journal:  Immunol Res       Date:  2002       Impact factor: 2.829

3.  Cytotoxic HIV-1 p55gag-specific CD4+ T cells produce HIV-inhibitory cytokines and chemokines.

Authors:  Barbara Lotti; Thomas Wendland; Hansjakob Furrer; Nikhil Yawalkar; Salome von Greyerz; Karin Schnyder; Marlène Brandes; Pietro Vernazza; Ralf Wagner; Thi Nguyen; Eric Rosenberg; Werner J Pichler; Christian Brander
Journal:  J Clin Immunol       Date:  2002-09       Impact factor: 8.317

4.  Expression of adenoviral E3 transgenes in beta cells prevents autoimmune diabetes.

Authors:  M G von Herrath; S Efrat; M B Oldstone; M S Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

5.  Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.

Authors:  N R Chu; H B Wu; T Wu; L J Boux; M I Siegel; L A Mizzen
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

6.  Stimulation via CD40 can substitute for CD4 T cell function in preventing reactivation of a latent herpesvirus.

Authors:  S R Sarawar; B J Lee; S K Reiter; S P Schoenberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

7.  Selective expression of IL-7 receptor on memory T cells identifies early CD40L-dependent generation of distinct CD8+ memory T cell subsets.

Authors:  Katharina M Huster; Verena Busch; Matthias Schiemann; Kathrin Linkemann; Kristen M Kerksiek; Hermann Wagner; Dirk H Busch
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-25       Impact factor: 11.205

Review 8.  Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.

Authors:  Jason Botten; John Sidney; Bianca R Mothé; Bjoern Peters; Alessandro Sette; Maya F Kotturi
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

9.  Longitudinal requirement for CD4+ T cell help for adenovirus vector-elicited CD8+ T cell responses.

Authors:  Nicholas M Provine; Rafael A Larocca; Pablo Penaloza-MacMaster; Erica N Borducchi; Anna McNally; Lily R Parenteau; David R Kaufman; Dan H Barouch
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

10.  Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection.

Authors:  Julian Schulze Zur Wiesch; Georg M Lauer; Joerg Timm; Thomas Kuntzen; Martin Neukamm; Andrew Berical; Andrea M Jones; Brian E Nolan; Steve A Longworth; Victoria Kasprowicz; Cory McMahon; Alysse Wurcel; Ansgar W Lohse; Lia L Lewis-Ximenez; Raymond T Chung; Arthur Y Kim; Todd M Allen; Bruce D Walker
Journal:  Blood       Date:  2007-05-02       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.